Patient Square Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Patient Square Capital's XENE Position: Q3 2026 in Review
Patient Square Capital sold out of Xenon Pharmaceuticals (XENE) in Q3 2026, closing a stake of 220,000 shares — an estimated $13.3M sold.
Patient Square Capital first reported a position in XENE in Q4 2025 and held it in 3 quarters. The position peaked at $13.3M in Q2 2026. 286 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Patient Square Capital reported no remaining Xenon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Patient Square Capital sold 220,000 Xenon Pharmaceuticals shares in Q3 2026, an estimated $13.3M.
- Patient Square Capital first reported a position in Xenon Pharmaceuticals in Q4 2025 and held it in 3 quarters.
- Patient Square Capital's Xenon Pharmaceuticals position peaked at $13.3M in Q2 2026.
- 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Patient Square Capital's 13F filing for Q3 2026, filed 10 Nov 2026.